Skip to main content

Vascular causes of renal failure

  • Chapter
Renal Failure

Part of the book series: Developments in Nephrology ((DINE,volume 37))

Abstract

Vascular causes of renal failure are listed on Table 10.1 and break down into three categories: Vasomotor disturbances refer to changes in glomerular arteriolar tone that reduce glomerular capillary pressure and as a result decrease glomerular filtration. These are functional rather than structural disorders, since the fall in renal perfusion that usually occurs is not enough to cause ischemic injury to renal tissue. Small vessel involvement consists of the blockage of small arteries and arterioles by cholesterol crystals, thrombi or pathological processes in the vessel wall. Large vessel involvement comprises the occlusion of the renal arteries and their main branches by a variety of conditions. Main renal artery lesions are included here although they do not involve intrinsic renal structures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davidman M, Olson P, Kohen J, Leither T and Kjellstrand C. Iatrogenic renal disease. Arch Intern Med 1991; 151: 1809–1812.

    PubMed  CAS  Google Scholar 

  2. Niaudet P, Haj-Ibrahim M, Gagnadoux M-F and Broyer M. Outcome of children with acute renal failure. Kidney Int 1985; 28: S148–S151.

    Google Scholar 

  3. Hodson EM, Kjellstrand CM and Mauer SM. Acute renal failure in infants and children: outcome of 53 patients requiring hemodialysis. J Pediatr 1976; 93: 756–761.

    Google Scholar 

  4. Counahan R, Cameron JS, Ogg CS, Spurgeon P, Williams DG, Winder E and Chantier C. Presentation, management, complications and outcome of acute renal failure in childhood: five years’ experience. Br Med J 1977; 1: 599–602.

    PubMed  CAS  Google Scholar 

  5. Rengel M, Caro P, Fdez-Llebrez J, Vargas-Z F, Gomes F and Garcia L. Acute renal failure in children. Kidney Int 1985; 28: 299.

    Google Scholar 

  6. Stapleton FB, Jones DP and Green RS. Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1987; 1: 314–320.

    PubMed  CAS  Google Scholar 

  7. Jones AS, James E, Bland H and Groshong T. Renal failure in the newborn. Clin Pediat 1979; 18: 286–291.

    PubMed  CAS  Google Scholar 

  8. Davidson EW and Dunn MJ. Pathogenesis of the hepatorenal syndrome. Ann Rev Med 1987; 38: 361–372.

    PubMed  CAS  Google Scholar 

  9. Mahnensmith RL. Hypercalcemia, hypernatremia, and reversible renal insufficiency. Am J Kidney Dis 1992; 19: 604–608.

    PubMed  CAS  Google Scholar 

  10. Bennett WM. Management of acute renal failure in sepsis — clinical considerations. Circ Shock 1983; 11: 261–267.

    PubMed  CAS  Google Scholar 

  11. Vaz AJ. Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch Intern Med 1983; 143: 738–739.

    PubMed  CAS  Google Scholar 

  12. Badr KF, Kelley VE, Rennke HG and Brenner BM. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 1986; 30: 474–480.

    PubMed  CAS  Google Scholar 

  13. Packer M, Lee WH, Medina N, Yushak M and Kessler PD. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 1987; 106: 346–354.

    PubMed  CAS  Google Scholar 

  14. Hricik DE and Dunn MJ. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990; 1: 845–858.

    PubMed  CAS  Google Scholar 

  15. Diamond JR, Cheung JY and Fang LST. Nifedipine-induced renal dysfunction. Am J Med 1984; 77: 905–909.

    PubMed  CAS  Google Scholar 

  16. Eicher JC, Morelon P, Chalopin JM, Tanter Y, Louis P and Rifle G. Acute renal failure during nifedipine therapy in a patient with congestive heart failure. Crit Care Med 1988; 16: 1163–1164.

    PubMed  CAS  Google Scholar 

  17. Cacoub P, Deray JY, Deray G, Grosgogeat Y and Jacobs C. Nifedipine-induced acute renal failure. Clin Nephrol 1988; 29: 272–273.

    PubMed  CAS  Google Scholar 

  18. Conte G, Dal Canton A, Sabbatini M, Napodano P, De Nicola L, Gigliotti G et al. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989; 36: 1086–1092.

    PubMed  CAS  Google Scholar 

  19. Skorecki KL, Rutledge WP and Schrier RW. Acute cyclosporine nephrotoxicity — prototype for a renal membrane signalling disorder. Kidney Int 1992; 42: 1–10.

    PubMed  CAS  Google Scholar 

  20. Morales JM, Andres A, Prieto C, Arenas J, Ortuno B, Praga M et al. Severe reversible cyclosporine-induced acute renal failure. Transplantation 1988; 46: 163–164.

    PubMed  CAS  Google Scholar 

  21. Kone BC, Watson AJ, Gimenez LF and Kadir S. Acute renal failure following percutaneous transhepatic cholangiography. Arch Intern Med 1986; 146: 1405–1407.

    PubMed  CAS  Google Scholar 

  22. Anzari Z and Baldwin DS. Acute renal failure due to radiocontrast agents. Nephron 1975; 17: 28–40.

    Google Scholar 

  23. Nora N and Berns AS. Renal failure following cardiac angiography: a prospective study of diatrizoate and iopamidol. Kidney Int 1989; 35: 414.

    Google Scholar 

  24. Taliercio CP, McCallister SH, Holmes DR, Ilstrup DM and Vlietstra RE. Nephrotoxicity of nonionic contrast media after cardiac angiography. Am J Cardiol 1989; 64: 815–816.

    PubMed  CAS  Google Scholar 

  25. Gomes RE, Lois JF, Baker JD, McGlade CT, Bunnell DH and Hartzman S. Acute renal dysfunction in high-risk patients after angiography: comparison of ionic and nonionic contrast media. Radiology 1989; 170: 65–68.

    PubMed  CAS  Google Scholar 

  26. Aron NB, Feinfeld DA, Peters AT and Lynn RI. Acute renal failure associated with ioxaglate, a low-osmolality radiocontrast agent. Am J Kidney Dis 1989; 13: 189–193.

    PubMed  CAS  Google Scholar 

  27. Barrett BJ and Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 1993; 188: 171–178.

    PubMed  CAS  Google Scholar 

  28. Clive DM and Stoff JS. Renal syndromes associated with non-steroidal anti-inflammatory drugs. N Engl J Med 1984; 310: 563–572.

    PubMed  CAS  Google Scholar 

  29. Gurwitz JH, Avorn J, Ross-Degnan D and Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA 1990; 264: 471–475.

    PubMed  CAS  Google Scholar 

  30. Carmichael J and Shankel SW. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985; 78: 992–1000.

    PubMed  CAS  Google Scholar 

  31. Blackshear JL, Davidman M and Stillman T. Identification of risk for renal insufficiency from nonsteroid anti-inflammatory drugs. Arch Intern Med 1983; 143: 1130–1134.

    PubMed  CAS  Google Scholar 

  32. Hricik DE. Captopril-induced renal insufficiency and the role of sodium balance. Ann Intern Med 1985; 103: 222–223.

    PubMed  CAS  Google Scholar 

  33. Schwartz D, Averbuch M, Pines A, Kornowski R and Levo Y. Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure. Chest 1991; 100: 1558–1561.

    PubMed  CAS  Google Scholar 

  34. Taliercio CP, Vlietstra RE, Fisher LD and Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501–504.

    PubMed  CAS  Google Scholar 

  35. Levenson DJ, Skorecki KL, Newell GC and Narins RG. Acute renal failure associated with hepatobiliary disease. In: Brenner BM and Lazarus JM, editors. Acute renal failure. New York, Churchill Livingstone, 1988; 535–580.

    Google Scholar 

  36. Gentilini P and Laffi G. Renal functional impairment and sodium retention in liver cirrhosis. Digestion 1989; 43: 1–32.

    PubMed  CAS  Google Scholar 

  37. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterol 1993; 105: 229–236.

    CAS  Google Scholar 

  38. Lenz K, Hortnagl H, Druml W, Grimm G, Laggner A, Schneeweisz B et al. Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut 1989; 30: 90–96.

    PubMed  CAS  Google Scholar 

  39. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471–1477.

    PubMed  CAS  Google Scholar 

  40. Whelton A, Stout RL, Spilman PS and Klassen DK. Renal effects of ibuprofen, piroxican, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 1990; 112: 568–576.

    PubMed  CAS  Google Scholar 

  41. Toto RD, Mitchell HC, Lee H-C, Milam C and Pettinger WA. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 1991; 115: 513–519.

    PubMed  CAS  Google Scholar 

  42. Chapman AB, Gabow PA and Schrier RW. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med 1991; 115: 769–773.

    PubMed  CAS  Google Scholar 

  43. Murray BM, Venuto RC, Kohli R and Cunningham EE. Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine. Am J Kidney Dis 1990; 16: 66–69.

    PubMed  CAS  Google Scholar 

  44. Deray G, Le Hoang P, Aupetit B, Achour A, Rottembourg J, and Baumelou A. Enhancement of cyclosporine A nephrotoxicity by diclofenac. Clin Nephrol 1987; 27: 213.

    PubMed  CAS  Google Scholar 

  45. Harris KP, Jenkins D and Walls J. Nonsteroidal anti-inflammatory drugs and cyclosporine. Transplantation 1988; 46: 598–599.

    PubMed  CAS  Google Scholar 

  46. Berg KJ, Forre O, Djoseland O, Mikkelsen M, Narverud J and Rugstad HE. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clin Nephrol 1989; 31: 232–238.

    PubMed  CAS  Google Scholar 

  47. Epstein M. Renal prostaglandins and the control of renal function in liver disease. Am J Med 1986; 80: 46–54.

    PubMed  CAS  Google Scholar 

  48. Reams GP, Bauer JH and Gaddy P. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Hypertension 1986; 8: 290–297.

    PubMed  CAS  Google Scholar 

  49. Textor SC, Biscardi A, Bravo EL, Tarazi RC and Fouad FM. Acute renal failure during converting enzyme inhibition in patients with renal artery stenosis. American Soc Nephrol (abstract) 1982: 45.

    Google Scholar 

  50. Zarich S, Fang LST and Diamond JR. Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med 1985; 145: 108–112.

    PubMed  CAS  Google Scholar 

  51. Fang LST, Sirota RA, Ebert TH and Lichtenstein NS. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 1980; 140: 531–533.

    PubMed  CAS  Google Scholar 

  52. Greenberg A, Egel J, Thompson M, Bahnson H, Griffith B, Hardesty R et al. Renal failure in heart transplant patients receiving cyclosporin A. Clin Res 1983; 31: 429A.

    Google Scholar 

  53. Agus ZS and Goldfarb S. Calcium metabolism: normal and abnormal. In Arieff AI and DeFronzo RA, editors. Fluid, electrolyte, and acid-base disorders. New York, Churchill Livingstone, 1985; 511–574.

    Google Scholar 

  54. Wilkinson SP, Hirst D, Day DW and Williams R. Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure. J Clin Pathol 1978; 31: 101–107.

    PubMed  CAS  Google Scholar 

  55. Dudley FJ, Kanel GC, Wood LJ and Reynolds TB. Hepatorenal syndrome without avid sodium retention. Hepatology 1986; 6: 248–251.

    PubMed  CAS  Google Scholar 

  56. Baldus WP, Feichter RN and Summerskill WHJ. The Kidney in cirrhosis. I. Clinical and biochemical features of azotemia in hepatic failure. Ann Intern Med 1964; 60: 353–365.

    PubMed  CAS  Google Scholar 

  57. Papper S. Hepatorenal syndrome. In: Epstein M, editor. The kidney in liver disease. Elsevier Biomédical, New York, 1983: 2nd ed., 87–106.

    Google Scholar 

  58. Ring-Larsen H and Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut 1981; 22: 585–591.

    PubMed  CAS  Google Scholar 

  59. Wilkinson SP, Blendis LM and Williams R. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure. BMJ 1974; l: 186–189.

    Google Scholar 

  60. Cade R, Wagemaker H, Vogel S, Mars D, Hood-Lewis D, Privette M et al. Hepatorenal syndrome. Am J Med 1987; 82: 427–438.

    PubMed  CAS  Google Scholar 

  61. Davenport A and Finn R. Paracetamol (Acetaminophen) poisoning resulting in acute renal failure without hepatic coma. Nephron 1988; 50: 55–56.

    PubMed  CAS  Google Scholar 

  62. Newell GC. Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 1987; 9: 183–190.

    PubMed  CAS  Google Scholar 

  63. Byrd L and Sherman RL. Radiocontrast-induced acute renal failure: a clinical and pathophysiological review. Medicine 1979; 58: 270–279.

    PubMed  CAS  Google Scholar 

  64. Teruel JL, Marcen R, Onaindia JM, Serrano A, Quereda C and Ortuno J. Renal function impairment caused by intravenous urography. A prospective study. Arch Intern Med 1981; 141: 1271–1274.

    PubMed  CAS  Google Scholar 

  65. Shafi T, Chou S-Y, Porush JG and Shapiro WB. Infusion intravenous pyelography and renal function. Effect in patients with chronic renal insufficiency. Arch Intern Med 1978; 138: 1218–1221.

    PubMed  CAS  Google Scholar 

  66. Van Zee BE, Hoy WE, Talley TE and Jaenike JR. Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 1978; 89: 51–54.

    Google Scholar 

  67. Carvalho A, Rakowski TA, Argy WP and Schreiner GE. Acute renal failure following drip infusion pyelography. Am J Med 1978; 65: 38–45.

    Google Scholar 

  68. Martin-Paredero V, Dixon SM, Baker JD, Takiff H, Gomes AS, Busuttil RW et al. Risk of renal failure after major angiography. Arch Surg 1983; 118: 1417–1420.

    PubMed  CAS  Google Scholar 

  69. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR 1991; 157: 49–58.

    PubMed  CAS  Google Scholar 

  70. Rich MW and Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. Arch Intern Med 1990; 150: 1237–1242.

    PubMed  CAS  Google Scholar 

  71. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992; 182: 649–655.

    PubMed  CAS  Google Scholar 

  72. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramiti N, Friedman AC et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. AJR 1991; 157: 59–65.

    PubMed  CAS  Google Scholar 

  73. Saklayen MG. Atheroembolic renal disease: preferential occurrence in whites only. Am J Nephrol 1989; 9: 87–88.

    PubMed  CAS  Google Scholar 

  74. Fine MJ, Kapoor W and Falanga V. Cholesterol crystal em-bolization: a review of 221 cases in the English literature. J Vasc Dis 1987; 38: 769–784

    CAS  Google Scholar 

  75. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery 1989; 105: 737–746.

    PubMed  CAS  Google Scholar 

  76. Baxter BT, McGee GS, Flinn WR, McCarthy WJ, Pearce WH and Yao JST. Distal embolization as a presenting symptom of aortic aneurysms. Am J Surg 1990; 160: 197–201.

    PubMed  CAS  Google Scholar 

  77. Colt HG, Begg RJ, Saporito JJ, Cooper WM and Shapiro AP. Cholesterol emboli after cardiac catheterization. Medicine 1988; 67: 389–400.

    PubMed  CAS  Google Scholar 

  78. Fraser I, Ihle B and Kincaid-Smith P. Renal failure due to cholesterol emboli. Aust NZ J Med 1991; 21: 418–421.

    CAS  Google Scholar 

  79. Hyman BT, Landas SK, Ashman RF, Schelper RL and Robinson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987; 82: 1233–1237.

    PubMed  CAS  Google Scholar 

  80. Case Records of the Massachusetts General Hospital, Case 38-1993. N Engl J Med 1993; 329: 948–955.

    Google Scholar 

  81. Mannesse CK, Blankestijn PJ, Man In’t Veld AJ and Schalekamp MADH. Renal failure and cholesterol crystal embolization: a report of 4 surviving cases and a review of the literature. Clin Nephrol 1991; 36: 240–245.

    PubMed  CAS  Google Scholar 

  82. Kaufman JL, Stark K and Brolin RE. Disseminated atheroembolism from extensive degenerative atherosclerosis of the aorta. Surgery 1987; 102: 63–69.

    PubMed  CAS  Google Scholar 

  83. McGowan JA and Greenberg A. Cholesterol atheroembolic renal disease. Am J Nephrol 1986; 6: 135–139.

    PubMed  CAS  Google Scholar 

  84. Cosserat J, Bletry O, Frances C, Wechsler B, Piette JC, Kief-fer E et al. Embolies multiples de cholesterol simulant une periarterite noueuse. Presse Med 1992; 21: 557–564.

    PubMed  CAS  Google Scholar 

  85. Smith MC, Ghose MK and Henry AR. The clinical spectrum of renal cholesterol embolization. Am J Med 1981; 71: 171–180.

    Google Scholar 

  86. Meyrier A, Buchet P, Simon P, Fernet M, Rainfray M and Callard P. Atheromatous renal disease. Am J Med 1988; 85: 139–146.

    PubMed  CAS  Google Scholar 

  87. Ludmerer KM and Kissane JM. Progressive renal failure with hematuria in a 62 year old man. Am J Med 1981; 71: 468–474.

    Google Scholar 

  88. Endreny RG, Zipin S, Chazan J and King B. Atheroembolic renal disease — presentation and clinical course in ten patients. Am J Kidney Dis 1988; 11: A6

    Google Scholar 

  89. Williams HH, Wall BM and Cooke CR. Case report: reversible nephrotic range proteinuria and renal failure in atheroembolic renal disease. Am J Med Sci 1990; 299: 58–61.

    PubMed  CAS  Google Scholar 

  90. Wilson DM, Salazer TL, Farkouh ME. Eosinophiluria in atheroembolic renal disease. Am J Med 1991; 91: 186–190.

    PubMed  CAS  Google Scholar 

  91. Case Records of the Massachusetts General Hospital, Case 30-1986. N Engl J Med 1986; 315: 308–315.

    Google Scholar 

  92. Cosio FG, Zager RA and Sharma HM. Atheroembolic renal disease causes hypocomplementaemia. Lancet 1985; 1: 118–122.

    Google Scholar 

  93. Hendel RC, Cuenoud HF, Giansiracusa DF and Alpert JS. Multiple cholesterol emboli syndrome. Arch Intern Med 1989; 149: 2371–2374.

    PubMed  CAS  Google Scholar 

  94. O’Keeffe ST, Woods BO’B, Breslin DJ and Tsapatsaris NP. Blue toe syndrome. Arch Intern Med 1992; 152: 2197–2202.

    PubMed  Google Scholar 

  95. Donohoe JF. Scleroderma and the kidney. Kidney Int 1992; 41: 462–477.

    PubMed  CAS  Google Scholar 

  96. Kovalchik MT, Guggenheim SJ, Silverman MH, Robertson JS and Steigerwald JC. The kidney in progressive systemic sclerosis. Ann Intern Med 1978; 89: 881–887.

    PubMed  CAS  Google Scholar 

  97. LeRoy EC and Fleischmann RM. The management of renal scleroderma. Am J Med 1978; 64: 974–978.

    PubMed  CAS  Google Scholar 

  98. Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH Jr., Steen VD et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Medicine 1983; 62: 335–352.

    PubMed  CAS  Google Scholar 

  99. Steen VD, Medsger TA Jr., Osial TA Jr., Ziegler GL, Shapiro AP and Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 1984; 76: 779–786.

    PubMed  CAS  Google Scholar 

  100. Gavras H, Gavras I, Cannon PJ, Brunner HR and Laragh JH. Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis. Arch Intern Med 1977; 137: 1554–1558.

    PubMed  CAS  Google Scholar 

  101. Oliver JA and Cannon PJ. The kidney in scleroderma. Nephron 1977; 18: 141–150.

    PubMed  CAS  Google Scholar 

  102. Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC and LeRoy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine 1974; 53: 1–46.

    PubMed  CAS  Google Scholar 

  103. Salyer WR, Salyer DC and Heptinstall RH. Scleroderma and microangiopathic hemolytic anemia. Ann Intern Med 1973; 78: 895–897.

    PubMed  CAS  Google Scholar 

  104. Hultman P, Enestron S, Pollard KM and Tan EM. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin Exp Immunol 1989; 78: 470–472.

    PubMed  CAS  Google Scholar 

  105. Tan EM. Systemic autoimmunity and antinuclear antibodies. Clin Aspects Autoimmunity 1986; 1: 2–8.

    Google Scholar 

  106. Ferri C, Bernini L, Cecchetti R, Latorraca A, Marotta G, Pasero G et al. Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol 1991; 18: 1826–1832.

    PubMed  CAS  Google Scholar 

  107. Kagan A, Nissim F, Green L and Bar-Khayim Y. Scleroderma renal crisis without hypertension. J Rheumatol 1989; 16: 707–708.

    PubMed  CAS  Google Scholar 

  108. Gouge SF, Wilder K, Welch P, Sabnis SG and Antonovich TT. Scleroderma renal crisis prior to scleroderma. Am J Kidney Dis 1989; 14: 236–238.

    PubMed  CAS  Google Scholar 

  109. Sanders PW, Herrera GA and Ball GV. Acute renal failure without fibrotic skin changes in progressive systemic sclerosis. Nephron 1988; 48: 121–125.

    PubMed  CAS  Google Scholar 

  110. Zwettler U, Andrassy K, Waldherr R and Ritz E. Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kidney Dis 1993; 22: 53–56.

    PubMed  CAS  Google Scholar 

  111. Guelpa G, Lucsko M, Chaignon M and Guedon J. Hypertension arterielle maligne, aspect semiologique et prognostique. Schweiz med Wschr 1984; 114: 1870–1877.

    PubMed  CAS  Google Scholar 

  112. Yu S-H, Whitworth JA and Kincaid-Smith PS. Malignant hypertension: aetiology and outcome in 83 patients. Clin and Exper Theory and Pract 1986; A8: 1211–1230.

    Google Scholar 

  113. Gudbrandsson T, Hansson L, Herlitz H and Andren L. Malignant hypertension — improving prognosis in a rare disease. Acta Med Scand 1979; 206: 495–499.

    PubMed  CAS  Google Scholar 

  114. Pitcock JA, Johnson JG, Hatch FE, Acchiardo S, Muirhead EE and Brown PS. Malignant hypertension in blacks. Human Pathol 1976; 7: 333–346.

    CAS  Google Scholar 

  115. Mattern WD, Sommers SC and Kassirer JP. Oliguric acute renal failure in malignant hypertension. Am J Med 1972; 52: 187–197.

    PubMed  CAS  Google Scholar 

  116. Isles CG, McLay A and Jones JMB. Recovery in malignant hypertension presenting as acute renal failure. Quart J Med 1984; 23: 439–452.

    Google Scholar 

  117. Lawton WJ. The short-term course of renal function in malignant hypertensives with renal insufficiency. Clin Nephrol 1982; 17: 277–283.

    PubMed  CAS  Google Scholar 

  118. Krogsgaard AR, McNair A, Hilden T and Nielsen PE. Reversibility of cerebral symptoms in severe hypertension in relation to acute antihypertensive therapy. Acta Med Scand 1986; 220: 25–31.

    PubMed  CAS  Google Scholar 

  119. Nolan CR III and Linas SL. Accelerated and malignant hypertension. In: Shrier RW and Gottschalk CW, editors. Diseases of the kidney. Little Brown and Company, Boston. 1988: 1703–1826.

    Google Scholar 

  120. Gavras H, Oliver N, Aitchison J, Begg C, Briggs JD, Brown JJ et al. Abnormalities of coagulation and the development of malignant phase hypertension. Kidney Int 1975; 8: S252–S261.

    Google Scholar 

  121. Laragh JH, Ulick S, Januszewicz V, Deming QB, Kelly WG and Lieberman S. Aldosterone secretion and primary and malignant hypertension. J Clin Invest 1960; 39: 1091–1106.

    PubMed  CAS  Google Scholar 

  122. Mroczek WJ, Davidov M, Gavrilovich L, Finnerty FA Jr. et al. The value of aggressive therapy in the hypertensive patient with azotemia. Circulation 1969; 40: 893–904.

    Google Scholar 

  123. Patel R, Ansari A and Grim CE. Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. Am J Cardiol 1990; 66: 868–869.

    PubMed  CAS  Google Scholar 

  124. Sevitt LH, Evans DJ and Wrong OM. Acute oliguric renal failure due to accelerated (malignant) hypertension. Quart J Med 1971; 40: 127–144.

    PubMed  CAS  Google Scholar 

  125. Brown JJ, Davies DL, Lever AF and Robertson JIS. Plasma renin concentration in human hypertension. 1: Relationship between renin, sodium, and potassium. BMJ 1965; 2: 144–148.

    PubMed  CAS  Google Scholar 

  126. McNair A, Krogsgaard AR, Hilden T and Nielsen PE. Severe hypertension with cerebral symptoms treated with furosemide, fractionated diazoxide or dihydralazine. Acta Med Scand 1986; 220: 15–23.

    PubMed  CAS  Google Scholar 

  127. Fong JSC, de Chadarevian J-P and Kaplan BS. Hemolytic uremic syndrome. Current concepts and management. Pediatr Clin N Amer 1982; 29: 835–856.

    CAS  Google Scholar 

  128. Goldstein MH, Churg J, Strauss L and Gribetz D. Hemolytic-uremic syndrome. Nephron 1979; 23: 263–272.

    PubMed  CAS  Google Scholar 

  129. Neild G. The haemolytic uraemic syndrome: a review. Quart J Med 1987; 63: 367–376.

    PubMed  CAS  Google Scholar 

  130. Van Damme-Lombaerts, Proesmans W, Van Damme B, Eeckels R, Binda ki Muaka P, Mercieca V et al. Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study. J Pediatr 1988; 113: 913–918.

    Google Scholar 

  131. Martin DL, MacDonald KL, White KE, Soler JT and Osterholm MT. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 1990; 323: 1161–1167.

    PubMed  CAS  Google Scholar 

  132. van Wieringen PMV, Monnens LAH and Schretlen EDAM. Haemolytic-uraemic syndrome. Arch Dis Child 1974; 49: 432–437.

    PubMed  Google Scholar 

  133. Dolislager D and Tune B. The hemolytic-uremic syndrome. Am J Dis Child 1978; 132: 55–58.

    PubMed  CAS  Google Scholar 

  134. Sorrenti Y and Lewy PR. The hemolytic-uremic syndrome. Am J Dis Child 1978; 132: 59–62.

    PubMed  CAS  Google Scholar 

  135. Besser RE, Lett SM, Weber JT, Doyle MP, Barrett TJ, Wells JG et al. An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli 0157: H7 in fresh-pressed apple cider. JAMA 1993; 269: 2217–2220.

    PubMed  CAS  Google Scholar 

  136. Pavia AT, Nichols CR, Green DP, Tzuxe RV, Mottice S, Greene KD et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli 0157: H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 1990; 116: 544–551.

    PubMed  CAS  Google Scholar 

  137. Rowe PC, Orrbine E, Wells GA and McLaine PN, and members of the Canadian Pédiatrie Kidney Disease Reference Centre: epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. J Pediatr 1991; 119: 218–224.

    PubMed  CAS  Google Scholar 

  138. Ostroff SM, Kobayashi JM and Lewis JH. Infections with Escherichia coli 0157: H7 in Washington State. JAMA 1989; 262: 355–359.

    PubMed  CAS  Google Scholar 

  139. Griffin PM and Tauxe RV. The epidemiology of infections caused by Escherichia coli 0157: H7, other enterohemor-rhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiologic Reviews 1991; 13: 60–98.

    PubMed  CAS  Google Scholar 

  140. Brandt P, Jespersen J and Gregersen G. Post partum haemolytic-uraemic syndrome treated with antithrombin-III. Nephron 1981; 27: 15–18.

    PubMed  CAS  Google Scholar 

  141. Hayslett JP. Postpartum renal failure. N Engl J Med 1985; 312: 1556–1559.

    PubMed  CAS  Google Scholar 

  142. Souquiyyeh MZ and Kabir MZ. Postpartum hemolytic-uremic syndrome. Saudi Kidney Dis and Transplant Bull 1991; 2: 90–92.

    Google Scholar 

  143. Segonds A, Louradour N, Suc JM and Orfila C. Postpartum hemolytic uremic syndrome: a study of three cases with a review of the literature. Clin Nephrol 1979; 12: 229–242.

    PubMed  CAS  Google Scholar 

  144. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J et al. Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 1989; 7: 781–789.

    PubMed  CAS  Google Scholar 

  145. Murgo AJ. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 1987; 24: 161–177.

    PubMed  CAS  Google Scholar 

  146. Giroux L, Bettez P and Giroux L. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. Am J Kidney Dis 1985; 6: 28–39.

    PubMed  CAS  Google Scholar 

  147. Khansur T and Kennedy A. Case Report: cisplatin-induced hemolytic uremic syndrome. Am J Med Sci 1991; 301: 390–392.

    PubMed  CAS  Google Scholar 

  148. Eugene M, Deray G, Cacoub P, Achour A and Baumelou A. Hemolytic uremic syndrome and prostatic adenocar-cinoma. Clin Nephrol 1987; 27: 46.

    PubMed  CAS  Google Scholar 

  149. Avvento L, Gordon S, Silberberg JM, Zarrabi MH and Zucker S. Hemolytic uremic syndrome in a patient with small cell lung cancer. Am J Hematol 1988; 27: 221–223.

    PubMed  CAS  Google Scholar 

  150. Ortega Marcos O, Escuin F, Miguel JL, Gomez Fernandez P, Perez Fontan M, Selgas R et al. Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy. Clin Nephrol 1985; 24: 265–268.

    Google Scholar 

  151. Hauglustaine D, Van Damme B, Vanrenterghem Y and Michielsen P. Recurrent hemolytic uremic syndrome during oral contraception. Clin Nephrol 1981; 15: 148–153.

    PubMed  CAS  Google Scholar 

  152. Ashouri OS, Marbury TC, Fuller TJ, Gaffney E, Grubb WG and Cade JR. Hemolytic uremic syndrome in two postmenopausal women taking a conjugated estrogen preparation. Clin Nephrol 1982; 17: 212–215.

    PubMed  CAS  Google Scholar 

  153. Neill MA, Agosti J and Rosen H. Hemorrhagic colitis with Escherichia coli 0157: H7 preceding adult hemolytic uremic syndrome. Arch Intern Med 1985; 145: 2215–2217.

    PubMed  CAS  Google Scholar 

  154. Allan A, Keighley MRB and Thompson H. Beware of hemolytic uremic syndrome presenting as colorectal disease in adults. Dis Colon Rectum 1989; 32: 426–428.

    PubMed  CAS  Google Scholar 

  155. White DJ. Haemolytic uraemic syndrome in adults. BMJ 1988; 296: 899.

    PubMed  CAS  Google Scholar 

  156. Date A, Pulimood R, Jacob CK, Kirubakaran MG and Shastry JCM. Haemolytic-uraemic syndrome complicating snake bite. Nephron 1986; 42: 89–90.

    PubMed  CAS  Google Scholar 

  157. Siegler RL, Brewer ED and Pysher TJ. Hemolytic uremic syndrome associated with glomerular disease. Am J Kidney Dis 1989; 13: 144–147.

    PubMed  CAS  Google Scholar 

  158. Hagley MT, Hosney IA, Hulisz DT and Davis HH. Hemolytic-uremic syndrome associated with ingestion of quinine. Am J Nephrol 1992; 12: 192–195.

    PubMed  CAS  Google Scholar 

  159. Maguire RB, Stroncek DF and Campbell AC. Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies. Ann Intern Med 1993; 119: 215–217.

    PubMed  CAS  Google Scholar 

  160. Beaufils H, DeGroc F, Gubler MC, Wechsler B, LeHoang P, Baumelou A et al. Hemolytic uremic syndrome in patients with Behcet’s disease treated with cyclosporin A: report of 2 cases. Clin Nephrol 1990; 34: 157–162.

    PubMed  CAS  Google Scholar 

  161. Remuzzi G and Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 1989; 13: 261–272.

    PubMed  CAS  Google Scholar 

  162. Bonsib SM, Ercolani L, Ngheim D and Hamilton HE. Recurrent thrombotic microangiopathy in a renal allograft. Am J Med 1985; 79: 520–527.

    PubMed  CAS  Google Scholar 

  163. Butkus DE, Herrera GA and Raju SS. Successful renal transplantation after cyclosporine-associated hemolytic-uremic syndrome following bilateral lung transplantation. Transplantation 1992; 54: 159–189.

    PubMed  CAS  Google Scholar 

  164. Loomis LJ, Aronson AJ, Rudinsky R and Spargo BH. Hemolytic uremic syndrome following bone marrow transplantation: a case report and review of the literature. Am J Kidney Dis 1989; 14: 324–328.

    PubMed  CAS  Google Scholar 

  165. Cohen EP, Lawton CA, Moulder JE, Becker CG and Ash RC. Clinical course of late-onset bone marrow transplant nephropathy. Nephron 1993; 64: 626–636.

    PubMed  CAS  Google Scholar 

  166. Oursler DP, Holley KE and Wagoner RD. Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation. Am J Nephrol 1993; 13: 167–170.

    PubMed  CAS  Google Scholar 

  167. Esforzado N, Poch E, Almirall J, Lopez-Pedret J and Revert L. Hemolytic uremic syndrome associated with HIV infection. AIDS 1991; 5: 1041–1042.

    PubMed  CAS  Google Scholar 

  168. Frem GJ, Rennke HG and Sayegh MH. Late renal allograft failure secondary to thrombotic micro-angiopathy-human immunodeficiency virus nephropathy. J Am Soc Nephrol 1994; 4: 1643–1648.

    PubMed  CAS  Google Scholar 

  169. Ponticelli C, Rivolta E, Imbasciati E, Rossi E and Man-nucci PM. Hemolytic uremic syndrome in adults. Arch Intern Med 1980; 140: 353–357.

    PubMed  CAS  Google Scholar 

  170. Kaplan S. Hemolytic uremic syndrome with recurrent episodes: an important subset. Clin Nephrol 1977; 8: 495–498.

    PubMed  CAS  Google Scholar 

  171. Kaplan BS, Chesney RW and Drummond KN. Hemolytic uremic syndrome in families. N Engl J Med 1975; 292: 1090–1093.

    PubMed  CAS  Google Scholar 

  172. Mattoo TK, Mahmood MA, Al-Harbi MS and Mikail I. Familial, recurrent hemolytic-uremic syndrome. J Pediat 1989; 114: 814–816.

    PubMed  CAS  Google Scholar 

  173. Pirson Y, Lefebvre C, Arnout C and van Ypersele de Strihou C. Hemolytic uremic syndrome in three adult siblings: a familial study and evolution. Clin Nephrol 1987; 28: 250–255.

    PubMed  CAS  Google Scholar 

  174. Hakim RM, Schulman G, Churchill WH Jr. and Lazarus JM. Successful management of thrombocytopenia, microangiopathic anemia, and acute renal failure by plasmapheresis. Am J Kidney Dis 1985; 5: 170–176.

    PubMed  CAS  Google Scholar 

  175. Kaplan BS, Thomson PD and de Chadarevian J-P. The hemolytic uremic syndrome. Pediatr Clin N Amer 1976; 23: 761–777.

    CAS  Google Scholar 

  176. Morel-Maroger L, Kanfer A, Solez K, Sraer J-D and Richet G. Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): Clinicopathologic study in 20 adults. Kidney Int 1979; 15: 548–558.

    PubMed  CAS  Google Scholar 

  177. Bale JF Jr., Brasher C and Siegler RL. CNS manifestations of the hemolytic-uremic syndrome. Am J Dis Child 1980; 134: 869–872.

    PubMed  Google Scholar 

  178. Trevathan E and Dooling EC. Large thrombotic strokes in hemolytic-uremic syndrome. J Pediatr 1987; 111: 863–866.

    PubMed  CAS  Google Scholar 

  179. Upadhyaya K, Barwick K, Fishaut M, Kashgarian M and Siegel NJ. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatr 1980; 65: 115–1120.

    CAS  Google Scholar 

  180. Jolivet J, Giroux L, Laurin S, Gruber J, Bettez P and Band PR. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: A chemotherapy-induced syndrome. Cancer Treatment Reports 1983; 67: 429–434.

    PubMed  CAS  Google Scholar 

  181. Clarkson AR, Lawrence JR, Meadows R and Seymour AE. The haemolytic uraemic syndrome in adults. Quart J Med 1970; 39: 227–244.

    PubMed  CAS  Google Scholar 

  182. Habib R. Hemolytic uremic syndrome. In: Royer P, Habib R, Mathieu H and Broyer M, editors. Pédiatrie nephrology. W.B. Saunders Company, Philadelphia, 1974; 291–301.

    Google Scholar 

  183. O’Regan S and Rousseau E. Hemolytic uremic syndrome: urate nephropathy superimposed on an acute glomerulopathy? A hypothesis. Clin Nephrol 1988; 30: 207–210.

    PubMed  Google Scholar 

  184. Gonzalo A, Mampaso F, Gallego N, Bellas C, Segut J and Ortuno J. Hemolytic uremic syndrome with hypo-complementemia and deposits of IgM and C3 in the involved renal tissue. Clin Nephrol 1981; 16: 193–199.

    PubMed  CAS  Google Scholar 

  185. Poch E, Gonzalez-Clémente JM, Torras A, Darnell A, Botey A and Revert L. Silent renal microangiopathy after mitomycin C therapy. Am J Nephrol 1990; 10: 514–517.

    PubMed  CAS  Google Scholar 

  186. Case Records of the Massachusetts General Hospital, Case 41-1990. N Engl J Med 1990; 323: 1050–1061.

    Google Scholar 

  187. Sibai BM, Villar MA and Mabie BC. Acute renal failure in hypertensive disorders of pregnancy. Pregnancy outcome and remote prognosis in thirty-one. Am J Obstet Gynecol 1990; 162: 777–783.

    PubMed  CAS  Google Scholar 

  188. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC and Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501–509.

    PubMed  CAS  Google Scholar 

  189. Thiagarajah S, Bourgeois FJ, Harbert GM Jr. and Caudle MR. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 1984; 150: 1–7.

    PubMed  CAS  Google Scholar 

  190. Krane NK. Acute renal failure in pregnancy. Arch Intern Med 1988; 148: 2347–2357.

    PubMed  CAS  Google Scholar 

  191. McCrae KR, Samuels P and Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 1992; 80: 2697–2714.

    PubMed  CAS  Google Scholar 

  192. Ridolfi RL and Bell WR. Thrombotic thrombocytopenic purpura. Medicine 1981; 60: 413–428.

    PubMed  CAS  Google Scholar 

  193. Kennedy SS, Zacharski LR and Beck JR. Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases. Semin Thrombosis and Hemostasis 1980; 6: 341–349.

    CAS  Google Scholar 

  194. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA and The Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393–397.

    PubMed  CAS  Google Scholar 

  195. Bell WR, Braine HG, Ness PM and Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991; 325: 398–403.

    PubMed  CAS  Google Scholar 

  196. Rarick MU, Espina B, Mocharnuk R, Trilling Y and Levine AM. Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: a report of three cases and review of the literature. Am J Hematol 1992; 40: 103–109.

    PubMed  CAS  Google Scholar 

  197. Eknoyan G and Riggs SA. Renal involvement in patients with thrombotic thrombocytopenic purpura. Am J Nephrol 1986; 6: 117–131.

    PubMed  CAS  Google Scholar 

  198. Amorosi EL and Ultmann JE. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 1966; 45: 139–159.

    Google Scholar 

  199. Petitt RM. Thrombotic thrombocytopenic purpura: a thirty year review. Semin Thrombosis and Hemostasis 1980; 6: 350–355.

    CAS  Google Scholar 

  200. Pisciotta AV and Gottschall JL. Clinical features of thrombotic thrombocytopenic purpura. Semin Thrombosis and Hemostasis 1980; 6: 330–340.

    CAS  Google Scholar 

  201. Evans TL, Winkelstein A, Zeigler ZR, Shadduck RK and Mangan KF. Thrombotic thrombocytopenic purpura: clinical course and response to therapy in eight patients. Am J Hematol 1984; 17: 401–407.

    PubMed  CAS  Google Scholar 

  202. Kwaan HC. Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24: 71–81.

    PubMed  CAS  Google Scholar 

  203. Webb JG, Butany J, Langer G, Scott G and Liu PP. Myocarditis and myocardial hemorrhage associated with thrombotic thrombocytopenic purpura. Arch Intern Med 1990; 150: 1535–1537.

    PubMed  CAS  Google Scholar 

  204. Bukowski RM. Thrombotic thrombocytopenic purpura: a review. Prog Hemost Thromb 1982; 6: 287–337.

    PubMed  CAS  Google Scholar 

  205. Kovacs MJ, Roddy J, Grégoire S, Cameron W, Eidus L and Drouin J. Thrombotic thrombocytopenic purpura following hemorrhagic colitis due to Escherichia coli 0157: H7. Am J Med 1990; 88: 177–179.

    PubMed  CAS  Google Scholar 

  206. Case Records of the Massachusetts General Hospital, Case 30-1991. N Engl J Med 1991; 325: 265–273.

    Google Scholar 

  207. Kleinknecht D, Grunfeld J-P, Cia Gomez P, Moreau J-F and Garcia-Torres R. Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int 1973; 4: 390–400.

    PubMed  CAS  Google Scholar 

  208. Chugh KS, Singhal PC, Kher VK, Gupta VK, Malik GH, Narayan G et al. Spectrum of acute cortical necrosis in Indian patients. Am J Med Sci 1983; 286: 10–20.

    PubMed  CAS  Google Scholar 

  209. Matlin RA and Gary NE. Acute cortical necrosis. Am J Med 1974; 56: 110–118.

    PubMed  CAS  Google Scholar 

  210. Stratta P, Canavese C, Colla L, Dogliani M, Bussolino F, Bianco O, Gagliardi L, Todros T, Iberti M, Veronesi GV and Bianchi GM. Acute renal failure in preeclampsia. Gynecol Obstet Invest. 1987; 24: 225–232.

    PubMed  CAS  Google Scholar 

  211. Grunfeld J-P, Ganeval D and Bournerias F. Acute renal failure in pregnancy. Kidney Int 1980; 18: 179–191.

    PubMed  CAS  Google Scholar 

  212. Darwish R, Vaziri ND, Gupta S, Novey H, Spear GS, Licorish K et al. Focal renal cortical necrosis associated with zomepirac. Am J Med 1984; 76: 1113–1117.

    PubMed  CAS  Google Scholar 

  213. Amaral CFS, Da Silva OA, Godoy P and Miranda D. Renal cortical necrosis following Bothrops Jararaca and B. Jararacussu snake bite. Toxicon 1985; 23: 877–885.

    PubMed  CAS  Google Scholar 

  214. Schneider PD. Nonsteroidal anti-inflammatory drugs and acute cortical necrosis. Ann Intern Med 1986; 105: 303–304.

    PubMed  CAS  Google Scholar 

  215. Wells JD, Gordon Margolin E and Gall EA. Renal cortical necrosis. Am J Med 1960; 29: 257–267.

    PubMed  CAS  Google Scholar 

  216. Deutsch V, Frankl O, Drory Y, Eliahou H and Braf ZF. Bilateral renal cortical necrosis with survival through the acute phase with a note on the value of selective nephroangiography. Am J Med 1971; 50: 828–833.

    PubMed  CAS  Google Scholar 

  217. Goergen TG, Lindstrom RR, Tan H and Lilley JJ. CT appearance of acute renal cortical necrosis. AJR 1981; 137: 176–177.

    PubMed  CAS  Google Scholar 

  218. Cohen AH. Renal pathology forum. Am J Nephrol 1985; 5: 305–311.

    PubMed  CAS  Google Scholar 

  219. Whelan JG Jr., Ling JT and Davis LA. Antemortem roentgen manifestations of bilateral renal cortical necrosis. Radiology 1967; 89: 682–689.

    PubMed  Google Scholar 

  220. Papo J, Peer G, Aviram A and Paizer R. Acute renal cortical necrosis as revealed by computerized tomography. Isr J Med Sci 1985; 21: 862–863.

    PubMed  CAS  Google Scholar 

  221. Jordan J, Low R and Jeffrey RB Jr. CT findings in acute renal cortical necrosis. J Computer Assisted Tomography 1990; 14: 155–156.

    CAS  Google Scholar 

  222. Agarwal A, Sakhuja V, Malik N, Joshi K and Chugh KS. The diagnostic value of CT scan in acute renal cortical necrosis. Renal Failure 1992; 14: 193–196.

    PubMed  CAS  Google Scholar 

  223. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P and Moorhead JF. Atherosclerotic renovascular disease causing renal impairment — a case for treatment. Clin Nephrol 1989; 31: 119–122.

    PubMed  CAS  Google Scholar 

  224. Novick AC, Pohl MA, Schreiber M, Gifford RW Jr. and Vidt DG. Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease. J Urol 1983; 129: 907–912.

    PubMed  CAS  Google Scholar 

  225. Madias NE, Ball JT and Millan VG. Percutaneous transluminal renal angioplasty in the treatment of unilateral atherosclerotic renovascular hypertension. Am J Med 1981; 70: 1078–1084.

    PubMed  CAS  Google Scholar 

  226. De La Rocha AG, Zorn M and Downs AR. Acute renal failure as a consequence of sudden renal artery occlusion. Canad J Surg 1981; 24: 218–222.

    PubMed  Google Scholar 

  227. de Jong PE, van Bockel JH and de Zeeuw D. Unilateral renal parenchymal disease with contralateral renal artery stenosis of the fibrodysplasia type. Ann Intern Med 1989; 110: 438–446.

    Google Scholar 

  228. Wasser WG, Krakoff LR, Haimov M, Glabman S and Mitty HA. Restoration of renal function after bilateral renal artery occlusion. Arch Intern Med 1981; 141: 1647–1651.

    PubMed  CAS  Google Scholar 

  229. Madias NE, Kwon OJ and Millan VG. Percutaneous transluminal renal angioplasty. A potential effective treatment for preservation of renal function. Arch Intern Med 1983; 142: 693–697.

    Google Scholar 

  230. Jones RE, Tribble CG, Tegtmeyer CJ, Craddock GB Jr. and Mentzer RM Jr. Bilateral renal artery embolism: a diagnostic and therapeutic problem. J Vasc Surg 1987; 5: 479–482.

    PubMed  CAS  Google Scholar 

  231. Tegtmeyer CJ, Elson J, Glass TA, Ayers CR, Chevalier RL, Wellons HA Jr. et al. Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Radiology 1982; 143: 631–637.

    PubMed  CAS  Google Scholar 

  232. Sheps SG, Kincaid OW and Hunt JC. Serial renal function and angiographie observations in idiopathic fibrous and fibromuscular stenoses of the renal arteries. Am J Cardiol. 1972; 30: 55–60.

    PubMed  CAS  Google Scholar 

  233. Mestres CA, Campistol JM, Ninot S, Botey A, Abad C, Guerola M et al. Improvement of renal function in azotaemic hypertensive patients after surgical revascularization. Br J Surg 1988; 75: 578–580.

    PubMed  CAS  Google Scholar 

  234. Weiss RA, Jodorkovsky R, Weiner S, Bennett B, Kogan S, Greifer I and Bernstein R. Chronic renal failure due to Takayasu’s arteritis: recovery of renal function after nine months of dialysis. Clin Nephrol 1982; 17: 104–107.

    PubMed  CAS  Google Scholar 

  235. Sawaya B, Provenzano R, Kupin WL and Venkat KK. Cyclosporine-induced renal macroangiopathy. Am J Kidney Dis 1988; 12: 534–537.

    PubMed  CAS  Google Scholar 

  236. Rushton AR The genetics of fibromuscular dysplasia. Arch Intern Med 1980; 140: 233–236.

    PubMed  CAS  Google Scholar 

  237. Jacobson HR. Ischemic renal disease: an overlooked clinical entity? Kidney Int 1988; 34: 729–743.

    PubMed  CAS  Google Scholar 

  238. Besarab A, Brown RS, Rubin NT, Salzman E, Wirthlin L, Steinman T et al. Reversible renal failure following bilateral renal artery occlusive disease: clinical features, pathology, and the role of surgical revascularization. JAMA 1976; 235: 2838–2841.

    PubMed  CAS  Google Scholar 

  239. Heaney D, Kupor LR, Noon GP and Suki WN. Bilateral renal artery stenosis causing acute oliguric renal failure. Arch Surg 1977; 112: 641–643.

    PubMed  CAS  Google Scholar 

  240. Kaylor WM, Novick AC, Ziegelbaum M and Vidt DG. Reversal of end stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion. J Urol 1989; 141: 486–488.

    PubMed  CAS  Google Scholar 

  241. May J, Ross Sheil AG, Horvath J, Tiller DJ and Johnson JR. Reversal of renal failure and control of hypertension in patients with occlusion of the renal artery. Surgery 1976; 143: 411–413.

    CAS  Google Scholar 

  242. Libertino JA, Zinman L, Breslin DJ, Swinton NW Jr. and Legg MA. Renal artery revascularization. JAMA 1980; 244: 1340–1342.

    PubMed  CAS  Google Scholar 

  243. Cohen EP and Elliott WC Jr. The role of ischemia in acquired cystic kidney disease. Am J Kidney Dis 1990; 15: 55–60.

    PubMed  CAS  Google Scholar 

  244. Bardram L, Helgstrand U, Bentzen MH, Hansen HJB and Engell HC. Late results after surgical treatment of renovascular hypertension. Ann Surg 1985; 201: 219–224.

    PubMed  CAS  Google Scholar 

  245. Grim CE, Luft FC, Yune HY, Klatte EC and Weinberger MH. Percutaneous transluminal dilatation in the treatment of renal vascular hypertension. Ann Intern Med 1981; 95: 439–442.

    PubMed  CAS  Google Scholar 

  246. Sos TA, Pickering TG, Phil D, Sniderman K, Saddekni S, Case DB et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274–279.

    PubMed  CAS  Google Scholar 

  247. Dean RH, Oates JA, Wilson JP, Rhamy RK, Hollifield JW, Burko H et al. Bilateral renal artery stenosis and renovascular hypertension. Surgery 1977; 81: 53–62.

    PubMed  CAS  Google Scholar 

  248. Simon N, Franklin SS, Bleifer KH and Maxwell MH. Clinical characteristics of renovascular hypertension. JAMA 1972; 220: 1209–1218.

    PubMed  CAS  Google Scholar 

  249. Ying CY, Tifft CP, Gavras H and Chobanian AV. Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 1984; 311: 1070–1075.

    PubMed  CAS  Google Scholar 

  250. Messina LM, Zelenock GB, Yao KA and Stanley JC. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J Vasc Surg 1992; 15: 73–82.

    PubMed  CAS  Google Scholar 

  251. Diamond JR. Flash pulmonary edema and the diagnostic suspicion of occult renal artery stenosis. Am J Kidney Dis 1993; 21: 328–330.

    PubMed  CAS  Google Scholar 

  252. Remuzzi A, Schieppati A, Battaglia C and Remuzzi G. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome. Am J Kidney Dis 1989; 14: 170–177.

    PubMed  CAS  Google Scholar 

  253. Steensma-Vegter AJ, Krediet RT, Westra D and Tegzess AM. Reversible stenosis of the renal artery in cadaver kidney grafts: a report of three cases. Clin Nephrol 1981; 15: 102–106.

    PubMed  CAS  Google Scholar 

  254. Textor SC, Novick AC, Tarazi RC, Klimas V, Vidt DG and Pohl M. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 1985; 102: 308–314.

    PubMed  CAS  Google Scholar 

  255. Gerlock AJ Jr., MacDonell RC Jr., Smith CW, Muhletaler CA, Parris WCV, Johnson HK et al. Renal transplant arterial stenosis: Percutaneous transluminal angioplasty. AJR 1983; 140: 325–331.

    PubMed  Google Scholar 

  256. Muller FB, Sealey JE, Case DB, Atlas SA, Pickering TG, Pecker MS et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986; 80: 633–644.

    PubMed  CAS  Google Scholar 

  257. Morris GC, Jr., DeBakey ME and Cooley DA. Surgical treatment of renal failure of renovascular origin. JAMA 1962; 182: 609–612.

    Google Scholar 

  258. Mann SJ, Pickering TG, Sos TA, RG Uzzo, S Sarkar, K Friend et al. Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations. Am J Med 1991; 90: 30–40.

    PubMed  CAS  Google Scholar 

  259. Carmichael DJS, Mathias CJ, Snell ME and Peart S. Detection and investigation of renal artery stenosis. Lancet 1986; 1: 667–670.

    PubMed  CAS  Google Scholar 

  260. Kaufman JJ. Renovascular hypertension: the UCLA experience. J Urol. 1979; 121: 139–144.

    PubMed  CAS  Google Scholar 

  261. Zinman L and Libertino JA. Revascularization of the chronic totally occluded renal artery with restoration of renal function. J Urol 1977; 118: 517–521.

    PubMed  CAS  Google Scholar 

  262. Schefft P, Novick AC, Stewart BH and Straffon RA. Renal revascularization in patients with total occlusion of the renal artery. J Urol 1980; 124: 184–186.

    PubMed  CAS  Google Scholar 

  263. Mercier C, Piquet P, Alimi Y, Tournigand P and Albrand J-J. Occlusive disease of the renal arteries and chronic renal failure: the limits of reconstructive surgery. Ann Vase Surg 1990; 4: 166–170.

    CAS  Google Scholar 

  264. Setaro JF, Saddler MC, Chen CC, Hoffer PB, Roer DA, Markowitz DM et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991; 18: 289–298.

    PubMed  CAS  Google Scholar 

  265. Postma CT, van Oijen AHAM, Barentsz JO, de Boo T, Hoefnagels WHL, Corstens FHM et al. The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty. Arch Intern Med 1991; 151: 1531–1535.

    PubMed  CAS  Google Scholar 

  266. Erbsloh-Moller B, Dumas A, Roth D, Sfakianakis GN and Bourgoignie JJ. Furosemide-131I-hippuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension. Am J Med 1991; 90: 23–40.

    PubMed  CAS  Google Scholar 

  267. Distler A and Spies K-P. Diagnostic procedure in renovascular hypertension. Clin Nephrol 1991; 36: 174–180.

    PubMed  CAS  Google Scholar 

  268. Hoffmann U, Edwards JM, Carter S, Goldman ML, Harley JD, Zaccardi MJ et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991; 39: 1232–1239.

    PubMed  CAS  Google Scholar 

  269. Middleton WD. Doppler US evaluation of renal artery stenosis: past, present, and future. Radiology 1992; 184: 307–308.

    PubMed  CAS  Google Scholar 

  270. Kliewer MA, Tupler RH, Carroll BA, Paine SS, Kriegshauser JS, Hertzberg BS et al. Renal artery stenosis: analysis of Doppler waveform parameters and tardus-parvus pattern. Radiology 1993; 189: 779–787.

    PubMed  CAS  Google Scholar 

  271. Farrugia E, King BF and Larson TS. Magnetic resonance angiography and detection of renal artery stenosis in a patient with impaired renal function. Mayo Clin Proc 1993; 68: 157–160.

    PubMed  CAS  Google Scholar 

  272. Postma CT, Hartog O, Rosenbusch G and Thien T. Magnetic resonance angiography in the diagnosis of renal artery stenosis. J Hypertension 1993; 11: S204–S205.

    CAS  Google Scholar 

  273. Galanski M, Prokop M, Chavan A, Schaefer CM, Jandeleit K and Nischelsky JE. Renal arterial stenoses: spiral CT angiography. Radiology 1993; 189: 185–192.

    PubMed  CAS  Google Scholar 

  274. Rubin GD, Dake MD, Napel S, Jeffrey RB Jr., McDonnell CH, Sommer FG et al. Spiral CT of renal artery stenosis: comparison of three-dimensional rendering techniques. Radiology 1994; 190: 181–189.

    PubMed  CAS  Google Scholar 

  275. Roche Z, Rutecki G, Cox J and Whittier FC. Reversible acute renal failure as an atypical presentation of ischemic nephropathy. Am J Kidney Dis 1993; 22: 662–667.

    PubMed  CAS  Google Scholar 

  276. Zucchelli P, Fabbri L, Cagnoli L, Grimaldi C, Pavlica P and Losinno F. Acute renal failure due to renal artery occlusion. In: Eliahou HE, editor. Acute renal failure. John Libbey & Company Limited, London, 1982; 152–155.

    Google Scholar 

  277. Lessman RK, Johnson SF, Coburn JW and Kaufman JJ. Renal artery embolism: clinical features and long term follow-up of 17 cases. Ann Intern Med 1978; 89: 477–482.

    PubMed  CAS  Google Scholar 

  278. Mignon F, Meyrier A, Cuvelier R, Morel-Maroger L and Dewilde J. Reno-vascular complications of left atrial myx-oma: report of two patients. Kidney Int 1982; 22: 327.

    Google Scholar 

  279. Gill TJ and Dammin GJ. Paradoxical embolism with renal failure caused by occlusion of the renal arteries. Am J Med 1958; 25: 780–787.

    PubMed  Google Scholar 

  280. Gewertz BL, Stanley JC and Fry WJ. Renal artery dissections. Arch Surg 1977; 112: 409–414.

    PubMed  CAS  Google Scholar 

  281. Hasday JD, Sterns RH and Karch FE. Renal infarction due to renal artery dysplasia with dissection. Am J Med 1984; 76: 694–943.

    Google Scholar 

  282. Hirst AE Jr., Johns VJ Jr. and Kime SW Jr. Dissecting aneurysm of the aorta: a review of 505 cases. Medicine 1958; 37: 217–279.

    PubMed  Google Scholar 

  283. Hoover LA, Hall-Craggs M and Dagher FJ. Polyarteritis nodosa involving only the main renal arteries. Am J Kidney Dis 1988; 11: 66–69.

    PubMed  CAS  Google Scholar 

  284. Templeton PA and Pais SO. Renal artery occlusion in PAN. Radiology 1985; 156: 308.

    PubMed  CAS  Google Scholar 

  285. Elling H and Kristensen IB. Fatal renal failure in polymyalgia rheumatica caused by disseminated giant cell arteritis. Scand J Rheumatol 1980; 9: 206–208.

    PubMed  CAS  Google Scholar 

  286. Fogel RI, Endreny RG, Cronan JJ and Chazan JA. Acute renal failure with anuria caused by aortic thrombosis and bilateral renal artery occlusion. A report of two cases. RI Med J 1987; 70: 501–504.

    CAS  Google Scholar 

  287. Cosby RL, Miller PD and Schrier RW. Traumatic renal artery thrombosis. Am J Med 1986; 81: 890–894.

    PubMed  CAS  Google Scholar 

  288. DiPrete DA, Abuelo JG, Abuelo DN and Cronan JJ. Acute renal failure due to renal infarctions in a patient with neurofibromatosis. Am J Kidney Dis 1990; 15: 357–360.

    PubMed  CAS  Google Scholar 

  289. Bello Nicolau I, Conde Zurita JM, Barrientos Guzman A, Gutierrez Millet V, Ruilope Urioste LM, Prieto Carles C et al. Essential thrombocytosis with acute renal failure due to bilateral thrombosis of the renal arteries and veins. Nephron 1982; 32: 73–74.

    Google Scholar 

  290. Ames PRJ, Cianciaruso B, Bellizzi V, Balletta M, Lubrano E, Scarpa R et al. Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? J Rheumatol 1992; 19: 1802–1806.

    PubMed  CAS  Google Scholar 

  291. Franklin SS, Young JD Jr., Maxwell MH, Foster JH, Palmer JM, Cerny J et al. Operative morbidity and mortality in renovascular disease. JAMA 1975; 231: 1148–1153.

    PubMed  CAS  Google Scholar 

  292. Johansen K, Voci V, Cohen D and Fleet P. Acute bilateral renal artery occlusion. Arch Surg 1981; 116: 1232–1235.

    PubMed  CAS  Google Scholar 

  293. Lacombe M and Couffmhal J-C. Thromboses aigues de l’ere renale apres angiographie abdominale. La Nouv Presse med 1978; 7: 3333–3336.

    CAS  Google Scholar 

  294. Kuhlmann U, Greminger P, Gruntzig A, Schneider E, Pouliadis G, Luscher T et al. Long-term experience in percutaneous transluminal dilatation of renal artery stenosis. Am J Med 1985; 79: 692–698.

    PubMed  CAS  Google Scholar 

  295. Mahler F, Triller J, Weidmann P and Nachbur B. Complications in percutaneous transluminal dilatation of renal arteries. Nephron 1986; 44: 60–63.

    PubMed  Google Scholar 

  296. Baciewicz B. Bilateral renal artery thrombotic occlusion — a unique complication following removal of a transthoracic intraaortic balloon. Ann Thoracic Surg 1982; 33: 631–634.

    Google Scholar 

  297. Scully RE, Mark EJ, McNeely WF and McNeely BU. Case records of the Massachusetts General Hospital, Case 39-1987. N Engl J Med 1987; 317: 819–828.

    Google Scholar 

  298. Asherson RA, Buchanan N, Baguley E and Hughes GRV. Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. J Rheumatol 1993; 20: 874–876.

    PubMed  CAS  Google Scholar 

  299. Ricci MA and Lloyd DA. Renal venous thrombosis in infants and children. Arch Surg 1990; 125: 1195–1199.

    PubMed  CAS  Google Scholar 

  300. Pontremoli R, Rampoldi V, Morbidem A, Fiorini F, Ranise A and Garibotto G. Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. Nephron 1990; 56: 322–324.

    PubMed  CAS  Google Scholar 

  301. O’Donohoe MK, Donohoe J and Corrigan TP. Acute renal failure of renovascular origin: cure by aortorenal reconstruction after 25 days of anuria. Nephron 1990; 56: 92–93.

    PubMed  Google Scholar 

  302. Ewald EA, Griffin D and McCune J. Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa. J Rheumatol 1987; 14: 952–956.

    PubMed  CAS  Google Scholar 

  303. Travers RL, Allison DJ, Brettle RP and Hughes GRV. Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Sem in Arth Rheum 1979; 8: 184–199.

    CAS  Google Scholar 

  304. Llach F and Papper S. The clinical spectrum of renal vein thrombosis: Acute and chronic. Am J Med 1980; 69: 819–827.

    PubMed  CAS  Google Scholar 

  305. Wagoner RD, Stanson AW, Holley KE and Winter CS. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 1983; 23: 368–374.

    PubMed  CAS  Google Scholar 

  306. Trew PA, Biava CG, Jacobs RP and Hopper J Jr. Renal vein thrombosis in membranous glomerulonephropathy: Incidence and association. Medicine 1978; 57: 69–82.

    PubMed  CAS  Google Scholar 

  307. Schwartz MM and Lewis EJ. Immunopathology of the nephrotic syndrome associated with renal vein thrombosis. Am J Med 1973; 54: 528–534.

    PubMed  CAS  Google Scholar 

  308. Burrow CR, Walker WG, Bell WR and Gatewood OB. Streptokinase salvage of renal function after renal vein thrombosis. Ann Intern Med 1984; 100: 237–238.

    PubMed  CAS  Google Scholar 

  309. Rowe JM, Rasmussen RL, Mader SL, Dimarco PL, Cockett ATK and Marder VJ. Successful thrombolytic therapy in two patients with renal vein thrombosis. Am J Med 1984; 77: 1111–1114.

    PubMed  CAS  Google Scholar 

  310. Vogelzang RL, Moel DI, Cohn RA, Donaldson JS, Langman CB and Nemcek AA. Acute renal vein thrombosis: successful treatment with intraarterial urokinase. Radiology 1988; 169: 681–682.

    PubMed  CAS  Google Scholar 

  311. Gasparini M, Hofmann R and Stoller M. Renal artery embolism: clinical features and therapeutic options. J Urol 1992; 147: 567–572.

    PubMed  CAS  Google Scholar 

  312. Ouriel K, Andrus CH, Ricotta JJ, DeWeese JA and Green RM. Acute renal artery occlusion: when is revascularization justified? J Vasc Surg 1987; 5: 348–355.

    PubMed  CAS  Google Scholar 

  313. Choyke PL and Pollack HM. The role of MRI in diseases of the kidney. Radiol Clin N Amer 1988; 26: 617–631.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Abuelo, J.G. (1995). Vascular causes of renal failure. In: Abuelo, J.G. (eds) Renal Failure. Developments in Nephrology, vol 37. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0047-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0047-2_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4026-6

  • Online ISBN: 978-94-011-0047-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics